FRANCO, Vito
 Distribuzione geografica
Continente #
NA - Nord America 7.098
EU - Europa 3.403
AS - Asia 2.721
SA - Sud America 428
Continente sconosciuto - Info sul continente non disponibili 314
AF - Africa 79
OC - Oceania 6
Totale 14.049
Nazione #
US - Stati Uniti d'America 6.992
SG - Singapore 1.008
RU - Federazione Russa 750
CN - Cina 723
IT - Italia 636
FI - Finlandia 439
UA - Ucraina 395
BR - Brasile 343
HK - Hong Kong 312
DE - Germania 295
VN - Vietnam 225
IE - Irlanda 182
PL - Polonia 175
GB - Regno Unito 164
SE - Svezia 121
JP - Giappone 112
FR - Francia 111
BD - Bangladesh 68
KR - Corea 61
CA - Canada 47
IN - India 44
TR - Turchia 30
MX - Messico 27
NL - Olanda 27
CI - Costa d'Avorio 25
IQ - Iraq 24
AR - Argentina 23
BE - Belgio 22
VE - Venezuela 18
ZA - Sudafrica 16
AT - Austria 15
UZ - Uzbekistan 15
EC - Ecuador 14
CO - Colombia 12
RO - Romania 12
ES - Italia 11
SA - Arabia Saudita 11
CH - Svizzera 10
AZ - Azerbaigian 9
MA - Marocco 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
GR - Grecia 8
ID - Indonesia 8
PK - Pakistan 8
CL - Cile 7
PH - Filippine 7
CR - Costa Rica 6
KE - Kenya 6
MY - Malesia 6
AL - Albania 5
AU - Australia 5
IL - Israele 5
IR - Iran 5
JM - Giamaica 5
LB - Libano 5
CZ - Repubblica Ceca 4
EU - Europa 4
HN - Honduras 4
PY - Paraguay 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BO - Bolivia 3
HU - Ungheria 3
JO - Giordania 3
KZ - Kazakistan 3
LT - Lituania 3
NI - Nicaragua 3
NP - Nepal 3
OM - Oman 3
PR - Porto Rico 3
AO - Angola 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
LV - Lettonia 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
HT - Haiti 1
KG - Kirghizistan 1
KW - Kuwait 1
Totale 13.732
Città #
Ashburn 797
Fairfield 778
Singapore 658
Woodbridge 444
Chandler 433
Houston 377
San Jose 377
Wilmington 374
Hong Kong 307
Seattle 307
Cambridge 258
Ann Arbor 250
Jacksonville 220
Des Moines 180
Dublin 180
Zgierz 153
Beijing 133
Moscow 127
Santa Clara 127
Medford 126
Palermo 124
Tokyo 104
Nanjing 92
Frankfurt am Main 90
Princeton 78
Council Bluffs 76
Los Angeles 76
Ho Chi Minh City 69
Altamura 68
Lauterbourg 63
Lawrence 56
New York 56
San Diego 56
Hanoi 55
The Dalles 54
Tulsa 54
Boardman 52
Dearborn 49
Dallas 45
Hefei 42
Chicago 41
Helsinki 39
Buffalo 38
Nanchang 36
Hebei 31
Seongnam 29
Jinan 27
Changsha 26
São Paulo 26
Abidjan 25
Tianjin 24
Brussels 22
Shenyang 22
Amsterdam 20
Milan 20
Phoenix 20
Da Nang 18
Ludwigshafen am Rhein 18
Jiaxing 16
Verona 16
Columbus 15
Falls Church 15
Guangzhou 15
Kumar 15
London 15
Warsaw 15
Ningbo 14
Nuremberg 14
Zhengzhou 14
Saint Petersburg 13
Bremen 12
Izmir 12
Poplar 11
San Mateo 11
Atlanta 10
Brasília 10
Johannesburg 10
Shanghai 10
Tashkent 10
Toronto 10
Belo Horizonte 9
Cardiff 9
Denver 9
Norwalk 9
Orem 9
San Paolo di Civitate 9
Vancouver 9
Baku 8
Chennai 8
Rome 8
Auburn Hills 7
Biên Hòa 7
Brooklyn 7
Miami 7
Montreal 7
Munich 7
Salvador 7
Turku 7
Ankara 6
Battipaglia 6
Totale 8.885
Nome #
Associations between Notch-2, Akt-1 and HER2/neu expression in invasive human breast cancer: a tissue microarray immunophenotypic analysis on 98 patients. 308
Expression of cell cycle markers and human papillomavirus infection in oral squamous cell carcinoma:Use of fuzzy neural networks 295
Microenvironment-centred dynamics in aggressive B-cell lymphomas. 294
Splenic marginal zone lymphoma with or without villous lymphocytes 285
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi. 282
Challenges and new prospects in hepatosplenic γδ T-cell lymphoma. 272
Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma 257
CD27 distinguishes two phases in bone marrow infiltration of splenic marginal zone lymphoma 253
Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma. 251
Splenic marginal zone lymphoma: a prognostic model for clinical use. 241
C1q Production by Bone Marrow Stromal Cells 238
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis 236
An automated image analysis methodology for classifying megakaryocytes in chronic myeloproliferative disorders 233
Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis. 230
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. 229
Assessment of the Frequency of Additional Malignancies in Patients with Splenic Marginal Zone Lymphoma (SMZL) 227
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria 225
Clinical implications of a rare renal entity: Pleomorphic Hyalinizing Angiectatic Tumor (PHAT) 225
Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy 220
Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis. 220
Concomitant inflammatory pseudotumor of the liver and spleen 218
Constant detection of cyclooxygenase 2 in terminal stages of myeloid maturation. 217
D2-40 negative pyogenic granuloma-like Kaposi's sarcoma: Diagnostic features and histogenetic hypothesis of an uncommon skin tumor in HIV-negative patients. 215
Immunophenotypic profile and role of adhesion molecules in splenic marginal zone lymphoma with bone marrow involvement 210
Bone marrow fibrosis and diagnosis of essential thrombocythemia 209
European consensus on grading bone marrow fibrosis and assessment of cellularity 207
Circulating intercellular adhesion molecule-1 in chronic hepatitis C patients with normal or elevated aminotransferase before and after alpha-interferon treatment 204
Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: A Fondazione Italiana Linfomi phase II study 203
Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment 193
Does Exist A Correlation Between BMI and Gleason Patterns 4 and 5 At Prostate Biopsy? 189
CONTRIBUTO CLINICO AL GRANULOMA EOSINOFILO DELLE OSSA IN ETA' PEDIATRICA 188
HER2 status in advanced gastric carcinoma: A retrospective multicentric analysis from Sicily. 186
Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigation. 185
The sea urchin sns5 insulator protects retroviral vectors from chromosomal position effects by maintaining active chromatin structure 183
European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360-5-Comment 182
Morphological and biomolecular characteristics of subcentimetric invasive breast carcinomas in Sicily: A multicentre retrospective study in relation to trastuzumab treatment 177
ORAL LICHENOID DRUG REACTION BY LITHIUM IN A PATIENT WITH BIPOLAR DISORDER 176
Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoietic bone marrow histology. 174
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients 174
Differential diagnostic features of bone marrow biopsies in essential thrombocythemia 173
PLEOMORPHIC HYALINIZING ANGIOECTATIC TUMOR (PHAT) OF RENAL PARENCHYMA. FIRST CASE REPORTED IN LITERATURE 173
Gamma-delta T-cell lymphomas 172
Identification of CD162 in plasma-cell dyscrasia 171
Primary Plasma Cell Leukemia Associated with Adult Fanconi Syndrome 171
Megakaryocytic features useful for the diagnosis of myeloproliferative disorders can be obtained by a novel unsupervised software analysis 169
P-Selectin Glycoprotein Ligand-1 as a Potential Target for Humoral Immunotherapy of Multiple Myeloma 167
Nationwide interobserver variation in the diagnosis of follicular lymphoma: a report from the pathologists of GISL (Gruppo Italiano Studio Linfomi) 166
Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms. 166
Bone marrow evaluation according to the PVSG and WHO criteria in 90 essential thrombocythemia (ET) patients treated with PEG interferon alpha-2b. Preliminary results 164
CONGENITAL UNILATERAL URETEROPELVIC JUNCTION OBSTRUCTION:RENAL DAMAGE EVALUATION AND CORRELATION BETWEEN RENAL BIOPSY AND PRE-POSTOPERATIVE RADIONUCLIDE SCAN 164
Breast and chest wall metastatic seeding of adenocarcinoma of the colon with bone metaplasia: immunohistochemical study and differential diagnosis 164
Il riscontro diagnostico necroscopico 157
Bone Marrow Biopsy in Hodgkin Lymphoma 157
HSP10 selective preference for myeloid and megakaryocytic precursors in normal human bone marrow 156
Nationwide interobserver variation in the diagnosis of follicular lymphoma: a report from the pathologists of GISL (Gruppo Italiano Studio Linfomi) 153
Value of bone marrow biopsy in the diagnosis of essential thrombocythemia 152
Variant "Pyogenic granuloma-like" of Kaposi's Sarcoma in ACRAL location: our experience. 149
Sea urchin sns chromatin insulator prebents silencing and positional effect variegation of oncoretroviral vectors transgene expression in murine erythroid cell line 144
Nationwide interobserver variation in the diagnosis of follicular lymphoma. A study of the pathologists of GISL (Gruppo Italiano Studi Linfomi). 143
Reply to Pich et al.: intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma: a quantitative study. 138
Immunophenotypic profile and role of adhesion molecules in splenic marginal zone lymphoma with bone marrow involvement 138
Re: "Splenic marginal zone B-cell lymphoma associated with primary Sjögren's syndrome" 138
Pathophysiology of age-related diseases 137
The sea urchin chromatin insulator, sns-5 protect retrovirus vector from chromosomal position effects 135
Splenic marginal zone lymphoma with or without villous lymphocytes: Hematologic findings and outcomes in a series of 57 patients 122
Linfomi T maturi e biopsia osteomidollARE 115
PVSG and WHO bone marrow evaluation in 90 essential thrombocythaemia (ET) patients treated with Peg interferon A2b. Preliminary results 115
Manifestations of Hodgkin Lymphoma in the Bone Marrow 112
TRA ORRORE E SCIENZA: LA NASCITA DEL GABINETTO DI ANATOMIA PATOLOGICA DELL'UNIVERSITÀ' DI PALERMO 112
Functional characterization and use in the retrovirus vectors of the sea urchin SNS chromatin insulator in erythroid cells 110
Targeting CD162 for Multiple Myeloma immunotherapy. 108
Refertazione istopatologica e fattori prognostici del carcinoma mammario: requisiti minimi 101
Linfomi T maturi e biopsie osteomidollari 100
False versus true ET. Morphologic, immunophenotypic and molecular features 93
The "gray zone" of the Ph-negative myeloproliferative neoplasm; proposal of a decision tree useful in the differential diagnosis 92
Pattern of lymphoproliferations in the bone marrow 87
Morphological and biomolecular charachteristics of subcentimetric invasive breast carcinomas: a sicilian multicentric retrospective analysis 84
High risk Gleason patterns at prostate biopsy and body mass index. 70
Totale 14.049
Categoria #
all - tutte 46.334
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.334


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022914 0 206 15 58 39 35 54 35 117 106 67 182
2022/20231.210 108 206 11 126 151 185 140 99 116 6 45 17
2023/2024439 25 90 36 36 38 102 25 27 2 4 7 47
2024/20251.239 39 65 65 106 42 22 110 94 96 147 169 284
2025/20264.427 275 146 213 315 384 643 599 429 314 785 139 185
2026/2027263 212 51 0 0 0 0 0 0 0 0 0 0
Totale 14.049